RESEARCH INVESTMENTS (2005-2012)
$0 $1 $2 $3 $4 $5 $6 $7 $8
2005 2006 2007 2008 2009 2010 2011 2012
WHAT LIES AHEAD GRANTS-IN-AID OF RESEARCH 2012-2015
Dr. McKay
University of Calgary $358,336
Dr. Lomax Queen’s University $358,336
Dr. Gibson
University of British Columbia $358,336
Dr. Mallevaey University of Toronto $358,336
Drs. Surette, Moayyedi, Lee McMaster University $331,740
Dr. Jirik
University of Calgary $356,550
Drs. Amre, Mack, Deslandres, Janchou, Marcil University of Montreal/ CHU Ste-Justine
$299,350
Alternatively activated macrophages as a therapy for ulcerative colitis
Sympathetic neuroimmune
interactions during IBD
IBD risk through intestinal microbes and dietary fats
iNKT cells in IBD
Fecal biotherapy clinical trial in ulcerative colitis
Prion protein regulation of IBD in mice
Pre-clinical utility of epigenetic markers in Crohn’s disease in children
21 | RESEARCH REPORT 2012
Millions of Dollars
Page 1 |
Page 2 |
Page 3 |
Page 4 |
Page 5 |
Page 6 |
Page 7 |
Page 8 |
Page 9 |
Page 10 |
Page 11 |
Page 12 |
Page 13 |
Page 14 |
Page 15 |
Page 16 |
Page 17 |
Page 18 |
Page 19 |
Page 20 |
Page 21 |
Page 22 |
Page 23 |
Page 24